-
2022-501374-19-00
4
2022-09-16
Aggressive and Indolent B-cell Malignancies (mantle cell lymphoma; chr
-
2023-503795-24-00
7
2022-09-16
Avanced Non-Small Cell Lung Cancer
-
2022-502873-40-00
7
2022-06-13
Wilson disease
-
2023-506414-46-00
5
2022-04-22
High risk patients defined as having at least one of the following ris
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2023-506471-10-00
5
2019-10-04
Secondary hyperparathyroidism (SHPT) in pediatric patients with chroni
-
2026-526040-13-00
2
2026-05-25
No medical condition.
-
2025-521702-18-00
1
2026-05-21
Locally advanced unresectable or metastatic colorectal cancer (CRC)
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
-
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2024-513174-22-00
4
2026-04-14
Atrophic Age-related Macular Degeneration (AMD)
-
2025-522544-40-00
5
2026-03-27
Hereditary transthyretin-mediated amyloidosis with polyneuropathy
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2025-522046-42-00
5
2026-03-24
Colonic disease
-
2025-521284-12-00
5
2026-03-05
Non-small cell lung cancer
-
2024-519393-39-00
4
2026-02-27
Angelman Syndrome
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2024-515658-26-00
5
2026-01-21
Unresectable or Metastatic HER2 overexpressing and PD-L1 TPS <50% Non-
-
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
-
2024-516471-33-00
4
2026-01-19
Alport Syndrome
-
2025-522026-13-00
4
2026-01-12
Obsessive compulsive disorder
-
2024-519829-38-00
5
2026-01-09
Heart failure due to systemic left ventricular systolic dysfunction